Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07859228 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 1 Study of HCB303 in Participants With Advanced Malignancies

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A Phase 1, Open-label, Multi-regional, Multicenter, Dose escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Antitumor Activity of HCB303 in Participants with Advanced Malignancies
Trial Details
NCT Number NCT07859228
Lead Sponsor FBD Biologics Limited
Collaborators: HanchorBio Inc.
Conditions
(from sponsor)		 Advanced Malignancies
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov